Dr. Sandip Pravin Patel, MD

Dr. Patel practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Patel's NPI, 1245481381, was assigned on October 7, 2008. Dr. Patel graduated from Baylor College Of Medicine in 2008. Dr. Patel holds California license A110132.

Dr. Patel's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Patel's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Patel is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Patel to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Patel is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Patel's licenses on file in 2 states: California and North Carolina.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, lung cancer and neutropenia among the conditions Dr. Patel treats.

CMS data shows 685 Medicare services from Dr. Patel across 5 procedure codes in 2024, for 99 Medicare patients. Medicare paid $47,160 for them.

CMS counts 99 Medicare patients who saw Dr. Patel in 2024. The largest group is 75 to 84, with 43 patients. 75% of them have cancer, and 74% have high blood pressure. 29% are also on Medicaid. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 64, with 50% women.

In 2024, Dr. Patel wrote 514 Medicare Part D claims for 52 patients. 73% of them were for generic drugs. CMS names the drug for 396 of them, across 15 drugs with 11 or more claims each, at $1,384,819 in total drug cost. In 2023, CMS named 301 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

Dmand AI links 95 papers to Dr. Patel, published from 2005 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Immune Checkpoint Inhibitors. Dr. Patel has published most often in Clin Cancer Res. Dr. Patel's most frequent co-authors are Elad Sharon, MD, Charles David Blanke, MD and Razelle Kurzrock, MD.

Dmand AI links Dr. Patel to 14 clinical trials, 3 of them phase 1/2 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Melanoma and Carcinoma, Bronchogenic. Bristol-Myers Squibb sponsors the most, 5. Open Payments lists research payments to Dr. Patel that name 5 trials.

CMS Open Payments shows 358 general payments to Dr. Patel from 36 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. AstraZeneca Pharmaceuticals LP paid the most, $124,762. It also lists 15 research payments totaling $16,658 from 2016 to 2023, naming 5 clinical trials.

Dmand AI lists 10 awards for Dr. Patel, most recently Commendation for Excellence in Medical Student Teaching in 2009. Dr. Patel serves on NCCN and thymoma mesothelioma) NCCN.

Dr. Patel graduated from Baylor College Of Medicine in 2008.

Dr. Patel is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.